Aytu BioPharma (AYTU) Competitor Comparison
We are evaluating the key criteria listed to compare Aytu BioPharma (AYTU) against its competitors in the Biotechnology industry.
Market Capitalization
336 / 368Gross Profits
56 / 278Total Revenue
90 / 300EBITDA
36 / 337Free Cashflow
33 / 352Quick Ratio
336 / 357Earnings per Share
242 / 359Dividend yield
0 / 6Total Cash
298 / 358Performance 3 years
351 / 368Performance 5 years
357 / 368Performance 10 years
367 / 368Linearity 3 years
321 / 368Linearity 5 years
252 / 368Linearity 10 years
281 / 368Total Rank
214 / 368Dividend Rank
54 / 368Valuation Rank
274 / 368Piotroski Rank
90 / 368Muliplier Rank
287 / 368Total Cash - AYTU ranking 298 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.